Pixel, an AI healthcare solution company, participated in CES 2026, a global technology industry exhibition, to showcase its technological competitiveness to the global market, and announced that its AI eye health self-diagnosis solution was designated as an innovative product and registered on the public innovation procurement platform, Innovation Market Mall.
At CES 2026, Pixel unveiled AI-based digital healthcare technology, including self-diagnosis solutions for eye health and seniors. Based on medical device approval, the company showcased the solution's potential for public healthcare on an international stage.
Designated as an innovative product, Pixelro's AI eye health self-diagnosis solution provides non-face-to-face vision measurement and eye health self-diagnosis. Real-time eye tracking and left- and right-eye differentiation technology enhance test accuracy, and automatic correction of the user's testing environment and gaze state enhances reliability. Furthermore, it integrates with vital measurement functions like blood pressure and grip strength to provide integrated management of eye health information and overall health indicators. Test results can be stored and accessed via the cloud.
This solution, a medical device approved by the FDA, can be used in public healthcare settings such as health screenings for residents at public health centers, schools, and public facilities, eye health management for the elderly and students, and community-based preventive services. Pixel plans to streamline the adoption process for public institutions by registering with the Innovation Marketplace and promote the expansion of a prevention-focused digital healthcare model.
With its participation in CES 2026, Pixel is expanding its overseas partnerships and export collaborations, focusing on markets in North America, the Middle East, and Asia. The company explained that this exhibition and its innovative product designation have both recognized its technological prowess and its public utility value.
- See more related articles
You must be logged in to post a comment.